|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Cordis Corporation, a Johnson & Johnson Company providing devices and products for interventional vascular medicine and electrophysiology. |
|---|---|
| Transferring Party | LuMend, Inc., a provider of devices used to treat vascular disease in the legs and other parts of the body other than the heart. |
| Sector | Medical Devices |
| Date | September 28, 2005 |
| Analysis Provides Cordis with devices to treat chronic total occlusions, a peripheral vascular problem. Acquired product lines include special catheters to facilitate guidewire placement in minimally invasive procedures such as angioplasties and stenting. Complements Cordis Endovascular products. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |